September 1st 2024
A meta-analysis shows GLP-1 RAs and SGLT2 inhibitors offer distinct cardiovascular and kidney benefits in type 2 diabetes.
Rituximab May Slow Beta Cell Destruction in Type 1 Diabetes Patients
December 11th 2009Researchers at UT Southwestern and 14 other centers worldwide found that injections of the drug used to treat autoimmune disorders slowed beta cell destruction in the pancreas of those newly diagnosed with type 1 diabetes for at least a year.
Neurologic Disease and Pregnancy Outcomes
December 8th 2009Some neurologic disorders increase the risk of problematic outcomes of pregnancy. Data on such associations have been scant, but this is beginning to change. For example, with regard to epilepsy, there are a number of pregnancy registries which track outcomes related to antiepileptic drug therapy. However, large trials and population studies are not common.
Outlook Not as Grim for Type 2 Diabetics with Heart Disease, Study Says
December 3rd 2009Individuals with mild to moderate coronary heart disease, treated with intensive medical therapy alone, were no more likely to die from a heart problem after five years than those who also had an angioplasty procedure.
Cardiovascular Risk in Type 1 Diabetic Youths Linked Primarily to Insulin Resistance
December 2nd 2009Insulin resistance may affect long-term cardiovascular outcomes in type 1 diabetes and results indicate that insulin resistance is directly related to decreased heart and vessel function and appears to impair capacity to exercise.
Glucose Intolerance in Pregnancy Associated with Postpartum Cardiovascular Risk
December 2nd 2009Glucose intolerance during pregnancy predicts an increased likelihood of postpartum metabolic syndrome. In turn, cardiovascular risk factors at three months postpartum indicates that risk factors may be longstanding and contribute to long-term risk of cardiovascular disease.
VA Grant Spurs Development of Therapy for Neuropathic Pain
November 10th 2009A $1.8 million grant will help the University of Michigan investigate the use of herpes simplex virus-based vectors to deliver genes to sensory nerves from application in the skin, which researchers believe hold promise not only for the treatment of pain but also ultimately for the treatment of peripheral neuropathy itself.
Lifestyle Changes Could Prevent, Lower Incidence of Type 2 Diabetes
November 3rd 2009The Diabetes Prevention Program Outcomes Study finds that moderate health improvements such as modest weight loss or the use of anti-diabetic drugs can prevent or lower the incidence of type 2 diabetes in high risk populations.
Seas of Change for Inpatient Glucose Management
September 4th 2009Making the transition from outpatient to inpatient has been thankfully only a slightly “bumpy” road, but it is amazing looking back on how our approach to inpatient diabetes care and hyperglycemia on the whole has changed over the past 10 years.
FDA Warns on Potentially Fatal Glucose Monitor Readings
August 18th 2009Due to results that could mask significant hypoglycemia or prompt excessive insulin use, diabetics should never use GDH-PQQ glucose meters or test strips while using drug products or therapies that contain certain sugars other than glucose.